Confused about tirzepatide vs semaglutide for weight loss? Here’s a clear comparison of effectiveness, side effects, dosage, ...

Servier will acquire Day One Biopharmaceuticals for roughly $2.5 billion. But an analyst says other companies could make ...

U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing style ...

New findings from Spherix Global Insights’ Patient Chart Dynamix™: Lupus Nephritis (US), 2025 report reveal a treatment landscape in transition as specialists ...

A patient audit of more than 1,000 lupus nephritis charts highlights growing experience with biologics and calcineurin ...

OSAKA, Japan & CAMBRIDGE, Mass. & NEWARK, Calif., March 02, 2026--Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics, Inc. ("Protagonist") (NASDAQ:PTGX) today announced that the U.S. Food and ...

Hopefully this can be the first step in long overdue change that needs to occur in Britney’s life,” a representative for the ...

The company said its Phase II ZUPREME-1 trial in overweight or obese individuals without type 2 diabetes showed weight loss of 10.7% at week 42 on an efficacy estimand basis for t ...

Plenty of new dramas to enjoy this week, from the return of The Capture and Ellis to a new adaptation of A Woman of Substance ...

Bayer (XTRA:BAYN) has received preliminary US court approval for a multibillion-dollar class action settlement tied to Monsanto's Roundup weedkiller. The proposed agreement is intended to address tens ...

Discusses Phase II Results for HLP004 in Generalized Anxiety Disorder March 5, 2026 7:30 AM ESTCompany ParticipantsMichael Cola - ...